Sinopharm Group Co. Ltd

F:X2S Germany Medical Distribution
Market Cap
$3.27 Billion
€3.19 Billion EUR
Market Cap Rank
#3743 Global
#360 in Germany
Share Price
€2.37
Change (1 day)
+0.38%
52-Week Range
€1.96 - €2.37
All Time High
€2.71
About

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical … Read more

Sinopharm Group Co. Ltd - Asset Resilience Ratio

Latest as of June 2025: 0.00%

Sinopharm Group Co. Ltd (X2S) has an Asset Resilience Ratio of 0.00% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
€127.00K
Cash + Short-term Investments
Total Assets
€420.33 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2013–2024)

This chart shows how Sinopharm Group Co. Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Sinopharm Group Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €127.00K 0.0%
Total Liquid Assets €127.00K 0.00%

Asset Resilience Insights

  • Limited Liquidity: Sinopharm Group Co. Ltd maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Sinopharm Group Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Sinopharm Group Co. Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950
Medical Distribution 0.00%
Shenzhen Glory Medical Co Ltd
SHE:002551
Medical Distribution 10.46%
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
Medical Distribution -4.18%
Hanmi Science
KO:008930
Medical Distribution 0.06%
BCM Alliance Bhd
KLSE:0187
Medical Distribution 17.12%
Qingdao Baheal Medical INC.
SHE:301015
Medical Distribution 3.50%
Excelsior Medical Co Ltd
TW:4104
Medical Distribution 3.70%
CHC Healthcare Group
TW:4164
Medical Distribution 0.46%

Annual Asset Resilience Ratio for Sinopharm Group Co. Ltd (2013–2024)

The table below shows the annual Asset Resilience Ratio data for Sinopharm Group Co. Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.00% €158.00K €392.83 Billion 0.00pp
2023-12-31 0.00% €547.00K €383.39 Billion +0.00pp
2022-12-31 0.00% €498.00K €364.78 Billion 0.00pp
2021-12-31 0.00% €11.75 Million €335.41 Billion -0.01pp
2020-12-31 0.01% €39.14 Million €311.24 Billion +0.01pp
2019-12-31 0.00% €156.00K €269.89 Billion -0.02pp
2018-12-31 0.02% €41.20 Million €235.77 Billion -0.09pp
2017-12-31 0.10% €175.61 Million €169.54 Billion +0.10pp
2016-12-31 0.00% €5.47 Million €157.71 Billion -0.88pp
2015-12-31 0.88% €1.23 Billion €139.43 Billion -0.04pp
2014-12-31 0.93% €1.19 Billion €128.66 Billion +0.10pp
2013-12-31 0.83% €874.07 Million €105.45 Billion --
pp = percentage points